Latest Breaking News On - Corrona pharmacovigilance - Page 1 : comparemela.com

This randomized clinical trial evaluates the benefits and risks of the addition of a P2Y12 inhibitor to anticoagulant therapy compared with anticoagulant therap

New yorkUnited statesProvince of ontarioEspero biopharmaBoehringer ingleheimNigro maiaDaiichi sankyoOliveira antunesLopez sendon morenoBaumann kreuzigerBoeringher ingleheimJeffreys bergerCorrona pharmacovigilanceCerus corpAbbott vascular incSunovion pharmaceuticals